Characteristics and Management of Ganglioneuroma and Ganglioneuroblastoma-intermixed in Children and Adolescents
Overview
Oncology
Pediatrics
Affiliations
Background: Ganglioneuromas (GNs) usually demonstrate favorable histological and clinical features. Surgery is often performed due to clinical symptoms and/or theoretical concerns that GN may transform into neuroblastoma (NB); however, several studies have identified significant GN-surgical morbidities.
Objectives: We compared the natural history, biological and clinical features of GN and ganglioneuroblastoma-intermixed (GNB-I) managed by surgery or observation to inform management and surveillance.
Procedures: This retrospective study includes patients (n = 67) with histological diagnosis of GN (50/67) and GNB-I (17/67) at the Hospital for Sick Children between 1990 and 2014. Clinical, pathological features, tumor dimensions, and management were recorded.
Results: Median age and maximal tumor diameter were 6 years (1.3-17.8) and 6.3 cm (1.4-16.9), respectively. Of the 67 patients, 46 (69%) had upfront surgery and 21 (31%) were observed. Of the 21 observed patients 4 later underwent resection. There were post-operative complications in 15 of the 50 (30%) surgical patients. The presence of imaging-defined risk factors correlated with complications (P = 0.005). Observed patients were older (median 8.4 vs. 5.3 years) and diagnosed more recently. Median growth was 0.3 cm/year and 6 of 21 had progressive disease (PD). At median follow-up of 2.2 years (0.2-14.3), all patients were alive and for those with evaluable imaging there were 27 complete and 10 partial responses, 19 stable and 6 PD. Pathology classification changed at resection for three cases, but no GN was reclassified to NB.
Conclusions: GN and GNB-I have a slow growth rate and resection can be associated with significant morbidity. Watch and wait approaches should be considered for some GN and GNB-I.
Yokoyama K, Matsuki M, Isozaki T, Ito K, Imokawa T, Ozawa A Jpn J Radiol. 2025; .
PMID: 39794659 DOI: 10.1007/s11604-025-01732-6.
Paravertebral Ganglioneuroma in Pediatric Age: A Case Report.
Lasca A, Laia I, Pires Santos R, Dias Carneiro A, Moreira D Cureus. 2024; 16(6):e63363.
PMID: 39070384 PMC: 11283751. DOI: 10.7759/cureus.63363.
Wang H, Chen X, He L, Ding H, Xie M, Cai J Abdom Radiol (NY). 2024; 49(8):2942-2952.
PMID: 38900321 DOI: 10.1007/s00261-024-04411-8.
Tocan V, Nakamura-Utsunomiya A, Sonoda Y, Matsuoka W, Mizuguchi S, Muto Y Int J Mol Sci. 2024; 25(5).
PMID: 38474067 PMC: 10931978. DOI: 10.3390/ijms25052820.
Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
Prabaharan H, Chandrasekaran S, Shetty N, Nayak K P BMJ Case Rep. 2024; 17(2).
PMID: 38417946 PMC: 10900366. DOI: 10.1136/bcr-2023-256846.